The lipopolysaccharide-induced up-regulation of bradykinin B 2-receptor in the mouse heart is mediated by tumor necrosis factor-α and angiotensin II

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 6, 2006, Pages 1143-1147

  Yayama, Katsutoshi ^a   Hiyoshi, Hiromi ^a   Sugiyama, Kaori ^a   Okamoto, Hiroshi ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Bradykinin B2 receptor; Heart; Lipopolysaccharide (LPS); Tumor necrosis factor (TNF )

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; BRADYKININ B2 RECEPTOR; ENDOTHELIN 1; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LOSARTAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; HEART ARREST; HEART MUSCLE CELL; HEART RATE; IN VIVO CULTURE; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; SEPSIS; UPREGULATION;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, MONOCLONAL; BLOOD PRESSURE; CELLS, CULTURED; HEART; HEART RATE; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED STRAINS; MYOCARDIUM; MYOCYTES, CARDIAC; RECEPTOR, BRADYKININ B2; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 33744942351     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1143     Document Type: Article

References (44)

1. Wheeler A. P., Bernard G. R., N. Engl. J. Med., 340, 207-214 (1999).
2. Cadena D., Suffredini A. F., Page J. D., Pixley R. A., Kaufman N., Blood, 8, 3313-3317 (1993).
3. Suffredini A. F., Fromm R. E., Parker M. M., Brenner M., Kovacs J. A., Wesley R. A., Parrillo J. E., N. Engl. J. Med., 321, 280-287 (1989).
4. Leeb-Lundberg L. M., Marceau F., Müller-Esterl W., Pettibone D. J., Zuraw B. L., Pharmacol. Rev., 57, 27-77 (2005).
5. Linz W., Wiemer G., Schölkens B. A., Am. J. Cardiol., 80, 118A-123A (1977).
6. Kurisu S., Ozono R., Oshima T., Kambe M., Ishida T., Sugino H., Matsuura H., Chayama K., Teranishi Y., Iba O., Amano K., Matsubara H., Hypertension, 41, 99-107 (2003).
7. Liu Y. H., Yang X. P., Sharov V. G., Nass O., Sabbah H. N., Peterson E., Carretero O. A., J. Clin. Invest., 99, 1926-1935 (1997).
8. McLean P. G., Perretti M., Ahluwalia A., Cardiovasc. Res., 48, 194-210 (2000).
9. McLean P. G., Perretti M., Ahluwalia A., Br. J. Pharmacol., 128, 275-282 (1999).
10. Siebeck M., Spannagl E., Schorr M., Stumpf B., Fritz H., Whalley E. T., Cheronis J. C., Immunopharmacology, 33, 81-84 (1996).
11. Wilson D. D., de Garavilla L., Kuhn W., Togo J., Burch R. M., Steranka L.R., Circ. Shock, 27, 93-101 (1989).
12. Whalley E. T., Solomon J. A., Modafferi D. M., Bonham K. A., Cheronis J. C., Agents Actions, 38, 413-420 (1992).
13. Otterbein L., Lowe V. C., Kyle D. J., Noronha-Blob L., Agents Actions, 39, C125-C127 (1993).
14. Paya D., Stoclet J. C., Shock, 3, 376-379 (1995).
15. Simpson P., Savion S., Circ. Res., 50, 101-116 (1982).
16. Chomczynski P., Sacchi N., Anal. Biochem., 162, 156-159 (1987).
17. Yayama K., Horii M., Hiyoshi H., Takano M., Okamoto H., Kagota S., Kunitomo M., J. Pharmacol. Exp. Ther., 308, 736-743 (2004).
18. Zhang G., Ghosh S., J. Clin. Invest., 107, 13-19 (2001).
19. Comstock K. L., Krown K. A., Page M. T., Martin D., Ho P., Pedraza M., Castro E. N., Nakajima N., Glembotski C. C., Quintana P. J., Sabbadini R. A., J. Mol. Cell. Cardiol., 30, 2761-2775 (1998).
20. Baumgarten G., Knuefermann P., Nozaki N., Sivasubramanian N., Mann D. L., Vallejo J. G., J. Infect. Dis., 183, 1617-1624 (2001).
21. Frantz S., Kobzik L., Kim Y. D., Fukazawa R., Medzhitov R., Lee R. T., Kelly R. A., J. Clin. Invest. 104, 271-280 (1999).
22. Nemoto S., Vallejo J. G., Knuefermann P., Misra A., Defreitas G., Carabello B. A., Mann D. L., Am. J. Physiol. Heart. Circ. Physiol., 282, H2316-H2323 (2001).
23. Kapadia S., Lee J., Torre-Amione G., Birdsall H. H., Ma T. S., Mann D. L., J. Clin. Invest., 96, 1042-1052 (1995).
24. Sato H., Watanabe A., Tanaka T., Koitabashi N., Arai M., Kurabayashi M., Yokoyama T., J. Mol. Cell. Cardiol., 35, 1197-1205 (2003).
25. Yokoyama T., Sekiguchi K., Tanaka T., Tomaru K., Arai M., Suzuki T., Nagai R., Am. J. Physiol., 276, H1968-H1976 (1999).
26. Kintsurashvili E., Duka I., Gavras I., Johns C., Farmakiotis D., Gavras H., Am. J. Physiol. Heart Circ. Physiol., 281, H1778-H1783 (2001).
27. Schaller M. D., Waeber B., Nussberger J., Brunner H. R., Am. J. Physiol., 249, H1086-H1092 (1985).
28. Ohtani R., Ohashi Y., Muranaga K., Itoh N., Okamoto H., Life Sci., 44, 237-241 (1989).
29. Dunn C. W., Horton J. W., Circ. Shock, 40, 144-150 (1993).
30. Klett C., Hellmann W., Ganten D., Hackental E., Inflammation, 17, 183-197 (1993).
31. Lindpaintner K., Ganten D., Cir. Res., 68, 905-921 (1991).
32. Schindler R., Dinarello C. A., Koch K. M., Cytokine, 7, 526-533 (1995).
33. Peeters A. C., Netea M. G., Kullberg B. J., Thien T., van der Meer J. W., Immunology, 94, 376-379 (1998).
34. Niimi R., Nakamura A., Yanagawa Y., Jpn. J. Pharmacol., 88, 139-145 (2002).
35. Li H. L., Suzuki J., Bayna E., Zhang F. M., Dalle Molle E., Clark A., Engler R. L., Lew W. Y., Am. J. Physiol. Heart Circ. Physiol., 283, H461-H467 (2002).
36. Funakoshi Y., Ichiki T., Ito K., Takeshita A., Hypertension, 34, 118-125 (1999).
37. Ferreri N. R., Escalante B. A., Zhao Y., An S.-J., McGiff J. C., Am. J. Physiol. Renal Physiol., 274, F148-F155 (1998).
38. Meng X., Ao L., Meldrum D. R., Cain B. S., Shames B. D., Selzman C. H., Banerjee A., Harken A. H., Am. J. Physiol., 275, R502-R508 (1998).
39. Schulz R., Nava E., Moncada S., Br. J. Pharmacol., 105, 575-580 (1992).
40. Beutler B., Milsark I. W., Cerami A. C., Science, 229, 869-871 (1985).
41. Schulz R., Panas D. L., Catena R., Moncada S., Olley P. M., Lopaschuk G. D., Br. J. Pharmacol., 114, 27-34 (1995).
42. Meng X., Ao L., Brown J. M., Fullerton D. A., Banerjee A., Harken A. H., Shock 7, 111-118 (1997).
43. Fleming I., Dambacher T., Busse R., J. Cardiovasc. Pharmacol., 20, S135-S138 (1992).
44. Kasel A. M., Faussner A., Pfeifer A., Muller U., Werdan K., Roscher A. A., Diabetes, 45 (Suppl. 1), S44-S50 (1996).